Legato Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$400K Sell
1,748
-275
-14% -$61.6K 0.04% 580
2025
Q4
$431K Buy
2,023
+276
+16% +$57K 0.04% 611
2025
Q3
$347K Hold
1,747
0.04% 479
2025
Q2
$302K Hold
1,747
0.04% 497
2025
Q1
$272K Sell
1,747
-174
-9% -$24.9K 0.04% 498
2024
Q4
$264K Buy
1,921
+134
+7% +$17.6K 0.03% 511
2024
Q3
$267K Sell
1,787
-2,537
-59% -$343K 0.03% 518
2024
Q2
$590K Buy
4,324
+2,708
+168% +$368K 0.08% 396
2024
Q1
$244K Hold
1,616
0.03% 520
2023
Q4
$204K Buy
+1,616
New +$161K 0.03% 528
2023
Q1
Sell
-2,701
Closed -$330K 500
2022
Q4
$330K Buy
+2,701
New +$314K 0.06% 406

Other funds holding ASND